Portfolio Company · Operating Co.
Company Snapshot
Tally Bio is a life sciences portfolio company held by DCVC. Profile compiled from public sources; submit updates to extend the public record.
Ownership Context
Tally Bio is a current portfolio company of DCVC. Public coverage of this company is grouped under its parent firm's profile.
Sources
https://www.dcvc.com/portfolioThis profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Tally Bio and does not provide investment advice.
Other portfolio companies of DCVC
136 Avenue
13674648 (formerly 1366 Technologies)
Energy
17 Capital
Fintech
Abacus.AI
AbCellera
Life Sciences
AbSci
Aditazz
Enterprise
Agility Robotics
See the full DCVC portfolio.
Other Life Sciences portfolio companies
LGC Group
via omnes capital
Nurix Therapeutics
via general atlantic
Seaport Therapeutics
via general atlantic
Browse all PE-backed companies.